DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

DRG Oncology Pulse

Stay on top of updates and innovations in the oncology landscape and how it impacts your decisions

Expanding Horizons in Advanced Breast Cancer

View more

A timeline of key moments in the development of checkpoint inhibitors

View more

PARP Inhibitors Updates from ESMO 2018

View more
Ask us your question

Libtayo's FDA Approval: What to Expect from this Novel PD-1 Inhibitor

View more
Ask us your question

Oncology Marketing Perspectives

View more

Blood Cancer Awareness Month: Key Trends in the Hematology Oncology Market

View more

Upping the Ante in the Fight Against Cancer

View more

How Mylan Used Partnering Deals To Become A Key Player In Biosimilars

View more

The Role of CAR T-cells in Hematology Malignancies

View more